Literature DB >> 33112287

Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review.

Nienke van Welie1, Maite Portela1, Kim Dreyer1, Linda J Schoonmade2, Madelon van Wely3, Ben Willem J Mol4, Adrianus S P van Trotsenburg5, Cornelis B Lambalk1, Velja Mijatovic1, Martijn J J Finken6.   

Abstract

OBJECTIVE: Thyroid dysfunction is a known side effect of iodinated contrast media. There is some evidence to suggest that iodinated contrast media administered to pregnant women may cause thyroid dysfunction not only in themselves but also in their offspring. Here, we systematically evaluated literature on the use of iodinated contrast media prior to or during pregnancy on the offspring's thyroid function.
DESIGN: Systematic review of published literature.
MATERIALS AND METHODS: Relevant studies were identified by PubMed, EMBASE and The Cochrane Library up to June 5, 2020. All study designs, reporting on the foetal or neonatal thyroid function after exposure to iodinated contrast media prior to or during pregnancy, were included. We undertook random effects meta-analysis and pooled the estimates as proportions with 95% CIs.
RESULTS: We identified 402 articles, of which 26 were included. Six studies reported (n = 369) on exposure to iodinated contrast media prior to pregnancy by hysterosalpingography and 20 studies (n = 670) on exposure to these media during pregnancy by amniofetography, urography or CT. There was low to high risk of bias. The proportion of (transient) neonatal thyroid dysfunction was 0.0% (95% CI: 0.0-2.9% based on 3 studies) for hysterosalpingography, 2.25% (95% CI: 0.03-6.55% based on 2 studies) for amniofetography and 0.0% (95% CI: 0.0-0.02% based on 5 studies) for CT. There was a tendency towards an increased risk of thyroid dysfunction with higher amounts of contrast used.
CONCLUSIONS: Exposure to iodinated contrast media prior to or during pregnancy may increase the risk of thyroid dysfunction in offspring. We recommend keeping the amount of contrast used as low as possible.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33112287     DOI: 10.1530/EJE-20-0627

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Iodine status and supplementation in pregnancy: an overview of the evidence provided by meta-analyses.

Authors:  Laura Croce; Luca Chiovato; Massimo Tonacchera; Elena Petrosino; Maria Laura Tanda; Mariacarla Moleti; Flavia Magri; Antonella Olivieri; Elizabeth N Pearce; Mario Rotondi
Journal:  Rev Endocr Metab Disord       Date:  2022-10-13       Impact factor: 9.306

Review 2.  Acute Ischemic Stroke in Pregnancy : A Practical Focus on Neuroimaging and Reperfusion Therapy.

Authors:  Marcin Wiącek; Antonina Oboz-Adaś; Katarzyna Kuźniar; Anna Karaś; Patryk Jasielski; Halina Bartosik-Psujek
Journal:  Clin Neuroradiol       Date:  2022-09-16       Impact factor: 3.156

Review 3.  MECHANISMS IN ENDOCRINOLOGY: The pathophysiology of transient congenital hypothyroidism.

Authors:  Catherine Peters; Nadia Schoenmakers
Journal:  Eur J Endocrinol       Date:  2022-06-20       Impact factor: 6.558

Review 4.  The Impact of Iodine Concentration Disorders on Health and Cancer.

Authors:  Mateusz Winder; Zofia Kosztyła; Aleksandra Boral; Piotr Kocełak; Jerzy Chudek
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

5.  The Impact of Preconceptional Hysterosalpingography with Oil-based Contrast on Maternal and Neonatal Iodine Status.

Authors:  Rongrong Li; Wei Chen; Yanping Liu; Liangkun Ma; Ling Qiu; Jianhua Han; Rui Li
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 3.060

6.  Hysterosalpingography with Oil-Soluble Contrast Medium Does Not Increase Newborn Hypothyroidism.

Authors:  Divya M Mathews; Jane M Peart; Neil P Johnson; Robert G Sim; Natasha L Heather; Dianne Webster; Susannah O'Sullivan; Paul L Hofman
Journal:  Int J Endocrinol       Date:  2022-02-22       Impact factor: 3.257

Review 7.  The Role of Iodine for Thyroid Function in Lactating Women and Infants.

Authors:  Maria Andersson; Christian P Braegger
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.